His primary areas of study are Tau protein, Alzheimer's disease, Pathology, Cell biology and Progressive supranuclear palsy. His Tau protein research incorporates elements of Pick's disease, Neurodegeneration and Exon. Nicolas Sergeant has researched Alzheimer's disease in several fields, including Epitope, Genetically modified mouse, Neuroscience and Amyloid.
His research investigates the connection between Pathology and topics such as Hippocampus that intersect with issues in Cortex, Kinase activity and Trinucleotide repeat expansion. His Cell biology research incorporates themes from Genetics, Cell culture, Alternative splicing, RNA splicing and Regulation of gene expression. Nicolas Sergeant works mostly in the field of Progressive supranuclear palsy, limiting it down to topics relating to Tauopathy and, in certain cases, Parkinsonism, Frontotemporal dementia and Dementia.
His main research concerns Tau protein, Pathology, Cell biology, Neuroscience and Phosphorylation. His work deals with themes such as Neurodegeneration, Tauopathy, RNA splicing, Exon and Gene isoform, which intersect with Tau protein. His Cell biology study combines topics in areas such as Genetics, Biochemistry, Presenilin and Amyloid precursor protein.
His Alternative splicing, Regulation of gene expression, Phenotype and microRNA study in the realm of Genetics connects with subjects such as Dicer. His studies in Neuroscience integrate themes in fields like Tau pathology, Genetically modified mouse and Disease, Amyloid. He combines subjects such as Molecular biology, PIN1 and Neuron with his study of Phosphorylation.
His scientific interests lie mostly in Sperm, Andrology, Neuroscience, Transgene and Biochemistry. His study in Neuroscience is interdisciplinary in nature, drawing from both Tau protein, Neurodegeneration, Tauopathy and Adenosine receptor. His Tau protein study is focused on Alzheimer's disease in general.
His Neurodegeneration research integrates issues from Mutation, Gliosis, Dementia, Myotonic dystrophy and Gene isoform. His Transgene study integrates concerns from other disciplines, such as Apolipoprotein E, CASS4 and Focal adhesion. His Biochemistry research is multidisciplinary, incorporating perspectives in Microtubule and Brain tissue.
Nicolas Sergeant mainly focuses on Transgene, Adenosine receptor, Tauopathy, Glutamate receptor and Neuroscience. His Transgene study incorporates themes from Apolipoprotein E, CASS4 and Neurodegeneration. His Pharmacology research extends to the thematically linked field of Adenosine receptor.
His studies deal with areas such as Hippocampal formation, Adenosine A2A receptor and Genetically modified mouse as well as Glutamate receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease
A. Delacourte;J.P. David;N. Sergeant;L. Buée.
Neurology (1999)
Massive CA1/2 Neuronal Loss with Intraneuronal and N-Terminal Truncated Aβ42 Accumulation in a Novel Alzheimer Transgenic Model
Caty Casas;Nicolas Sergeant;Jean-Michel Itier;Véronique Blanchard.
American Journal of Pathology (2004)
Nuclear Tau, a Key Player in Neuronal DNA Protection
Audrey Sultan;Fabrice Nesslany;Marie Violet;Séverine Bégard.
Journal of Biological Chemistry (2011)
Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms.
N Sergeant;A Wattez;A Delacourte.
Journal of Neurochemistry (1999)
Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach.
Nicolas Sergeant;Stepanie Bombois;Antoine Ghestem;Hervé Drobecq.
Journal of Neurochemistry (2003)
Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration
Sébastien S. Hébert;Sébastien S. Hébert;Aikaterini S. Papadopoulou;Pascal Smith;Marie-Christine Galas;Marie-Christine Galas.
Human Molecular Genetics (2010)
Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their τ isoform distribution and phosphorylation
A. Delacourte;N. Sergeant;A. Wattez;D. Gauvreau.
Annals of Neurology (1998)
Tau protein as a differential biomarker of tauopathies.
Nicolas Sergeant;André Delacourte;Luc Buée.
Biochimica et Biophysica Acta (2005)
Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1
Nicolas Sergeant;Bernard Sablonnière;Suzanna Schraen-Maschke;Antoine Ghestem.
Human Molecular Genetics (2001)
Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy
Charlotte Fugier;Arnaud F Klein;Caroline Hammer;Stéphane Vassilopoulos.
Nature Medicine (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Lille
University of Lille
University of Lille
University of Lille
Fujirebio (Belgium)
Université Paris Cité
Université Paris Cité
University of Lille
University of Rouen
Institut du Cerveau
University of Zaragoza
Aalto University
Indraprastha Institute of Information Technology Delhi
University of Manchester
Pennsylvania State University
University of Michigan–Ann Arbor
National Autonomous University of Mexico
Cornell University
The University of Texas at Austin
University of Wisconsin–Milwaukee
Université Paris Cité
University of Trento
Adelphi University
University of Porto
Harvard University
Institute of Astronomy and Astrophysics, Academia Sinica